Precautions when taking ensidipine

Enasidenib (Enasidenib) is an oral targeted inhibitor for a specific type of acute myeloid leukemia (AML). Its use requires patients and doctors to work closely and follow a series of precautions to ensure the safety and effectiveness of the drug. The following are some common precautions for taking:

1.Used under the guidance of a doctor: Patients should use ensidipine correctly under the guidance of a doctor. Doctors will formulate a personalized treatment plan based on the patient's specific situation, including the severity of the disease, the presence of IDH2 mutations and other factors, and provide detailed medication guidance.

2.Dosage and usage: Patients should strictly abide by the dosage and usage of the drug prescribed by the doctor, and do not change or stop the use of the drug at will. Typically, the recommended dose of ensidipine is 100 mg twice daily (50 mg twice daily), taken orally, preferably at the same time to ensure stable drug concentrations.

3.Interactions with food: Ensidipine can be taken with food, but high-fat foods should be avoided as high-fat foods may reduce the absorption rate of the drug.

4.Drug Interactions: While taking ensidipine, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may affect the metabolism of ensidipine, increasing side effects or reducing the effectiveness of treatment.

5.Pay attention to drug tolerance: In the early stages of treatment, patients may experience some adverse reactions, such as nausea, vomiting, fatigue, etc. These adverse reactions usually lessen as treatment progresses, but patients should promptly report any uncomfortable symptoms to their doctor so that the treatment plan can be adjusted in a timely manner.

6.Regular monitoring: During ensidipine treatment, patients need regular clinical examinations and laboratory tests to monitor their condition and drug safety. These tests may include hematology, liver function tests, etc.

7.Avoid pregnancy: Patients should avoid pregnancy while receiving ensidipine because the drug may cause damage to the embryo. Female patients should take effective contraceptive measures during treatment and continue to use contraception for a period of time after treatment is completed.

8.Use in children and elderly patients: The safety and effectiveness of ensidipine in children and elderly patients have not been established, so use in these populations needs to be cautious and follow physician recommendations.

In general, patients should closely follow the doctor's instructions while using ensidipine and pay attention to the dosage, usage and adverse reactions of the drug. Report any symptoms of discomfort to your doctor promptly and monitor them regularly to ensure the safety and effectiveness of the medication.